About
Emergo Therapeutics develops pharmaceutical treatments that modulate the immune system without causing immunosuppression, targeting conditions caused by cytokine dysregulation such as long COVID, influenza-like illnesses, and other respiratory viruses.
Explore Emergo Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.